Perfect Medical Industry Co., Ltd. (6543.TWO)
TWD 28.85
(0.0%)
TWD 28.85
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 149.87 Million | 105.61 Million | 4.44 Million | 118.19 Million | 95.97 Million |
| Net Income | 54.25 Million | 17.97 Million | 62.51 Million | 133.44 Million | 36.44 Million |
| Depreciation & Amortization | 56.85 Million | 55.78 Million | 48.4 Million | 39.48 Million | 33.85 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 3.17 Million | 30 Thousand | - | 3.01 Million | 3.05 Million |
| Change in working capital | 24.61 Million | 32.87 Million | -86.78 Million | -48.44 Million | 27.15 Million |
| Other non-cash items | 11.7 Million | 25.14 Million | 6.04 Million | 749 Thousand | -4.53 Million |
| Investing Cash Flow | -63.57 Million | -44.39 Million | -61.84 Million | -189.59 Million | -129.32 Million |
| Investments in PPE | -66.3 Million | -52.74 Million | -103.57 Million | -144.46 Million | -49.17 Million |
| Acquisitions | 13.1 Million | - | - | - | - |
| Investment purchases | -19 Million | - | - | -40.32 Million | - |
| Sales/Maturities of investments | - | - | 48.08 Million | - | - |
| Other Investing Activities | 7.77 Million | 1.8 Million | -9.2 Million | -9.78 Million | -80.14 Million |
| Financing Cash Flow | -16.4 Million | -85.53 Million | 81.77 Million | 101.42 Million | 68.44 Million |
| Debt repayment | -5.4 Million | -110.94 Million | -116.75 Million | -131.95 Million | -33.93 Million |
| Dividends payments | -16.89 Million | -14.42 Million | -58.77 Million | -27.42 Million | -27.42 Million |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | 45.6 Million | 27.88 Million | - | - |
| Other Financing Activities | 45.33 Million | -126.95 Million | 168.25 Million | 54.52 Million | 61.93 Million |
| Accounts receivables | -2.38 Million | -2.36 Million | -3.69 Million | -5.31 Million | -8.54 Million |
| Accounts payables | 3.14 Million | - | - | - | - |
| Inventory | 14.21 Million | 47.82 Million | -73.01 Million | -57.81 Million | 21.09 Million |
| Other working capital | 11.09 Million | -4.01 Million | 1.67 Million | 6.61 Million | 14.6 Million |
| Cash at beginning of period | 92.74 Million | 119.24 Million | 94.88 Million | 68.28 Million | 35.33 Million |
| Cash at end of period | 161.4 Million | 92.74 Million | 119.24 Million | 94.88 Million | 68.28 Million |
| Capital Expenditure | -66.3 Million | -52.74 Million | -103.57 Million | -144.46 Million | -49.17 Million |
| Effect of forex changes on cash | -1.23 Million | -2.19 Million | -9000.00 | -3.42 Million | -2.14 Million |
| Net cash flow / Change in cash | 68.66 Million | -26.5 Million | 24.36 Million | 26.59 Million | 32.94 Million |
| Free Cash Flow | 83.56 Million | 52.86 Million | -99.12 Million | -26.26 Million | 46.79 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 22.25 Million | 22.25 Million | 12.86 Million | 54.25 Million | 12.86 Million | 7.17 Million |
| Depreciation & Amortization | 13.81 Million | 13.81 Million | 14.18 Million | 56.85 Million | 14.18 Million | 14.24 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 1.13 Million | - | 1.12 Million | 3.17 Million | 1.12 Million | 463.5 Thousand |
| Change in working capital | -10 Million | -10 Million | 2.24 Million | 24.61 Million | 2.24 Million | 9.21 Million |
| Other non-cash items | 511.5 Thousand | 1.64 Million | 6.43 Million | 11.7 Million | 6.43 Million | 6.97 Million |
| Investing Cash Flow | -12 Million | -12 Million | -19.67 Million | -63.57 Million | -19.67 Million | -12.11 Million |
| Investments in PPE | -17.95 Million | -17.95 Million | -13.98 Million | -66.3 Million | -13.98 Million | -18.36 Million |
| Acquisitions | 5.29 Million | - | - | - | - | - |
| Investment purchases | - | - | - | -19 Million | - | - |
| Sales/Maturities of investments | 6.2 Million | - | - | - | - | - |
| Other Investing Activities | 5.94 Million | 5.94 Million | -5.68 Million | 7.77 Million | -5.68 Million | 6.25 Million |
| Financing Cash Flow | 41.59 Million | 41.59 Million | -1.72 Million | -16.4 Million | -1.72 Million | -6.47 Million |
| Debt repayment | -22.61 Million | - | - | -5.4 Million | - | - |
| Dividends payments | - | - | -8.44 Million | -16.89 Million | -8.44 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 107.87 Million | - | - | - | - | - |
| Other Financing Activities | 41.59 Million | 41.59 Million | 6.72 Million | 45.33 Million | 6.72 Million | -6.47 Million |
| Accounts receivables | -3.12 Million | -3.12 Million | 1.09 Million | -2.38 Million | 1.09 Million | -2.28 Million |
| Accounts payables | 2.67 Million | - | - | - | - | - |
| Inventory | -11.5 Million | -11.5 Million | -5.2 Million | 14.21 Million | -5.2 Million | 12.31 Million |
| Other working capital | 4.62 Million | 4.62 Million | 6.35 Million | 11.09 Million | 6.35 Million | -812.5 Thousand |
| Cash at beginning of period | 161.4 Million | - | - | 92.74 Million | - | - |
| Cash at end of period | 57.55 Million | 57.55 Million | 14.73 Million | 161.4 Million | 14.73 Million | 19.6 Million |
| Capital Expenditure | -17.95 Million | -17.95 Million | -13.98 Million | -66.3 Million | -13.98 Million | -18.36 Million |
| Effect of forex changes on cash | 256 Thousand | 256 Thousand | -723 Thousand | -1.23 Million | -723 Thousand | 105 Thousand |
| Net cash flow / Change in cash | -103.85 Million | 57.55 Million | 14.73 Million | 68.66 Million | 14.73 Million | 19.6 Million |
| Free Cash Flow | 9.76 Million | 9.76 Million | 22.86 Million | 83.56 Million | 22.86 Million | 19.71 Million |
EMMS
SAR
0N08
CMCX
INDOEURO
APN